Therefore, anti-EGFR nanobody 99mTc-D10 might be suitable in a clinical setting as non-invasive diagnostic tracer to not only detect small tumours but also to obtain information on the expression level of EGFR at the time of diagnosis and during disease progression. This evidence concerns the gene EGFR and neoplasm.